Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma

Leuk Lymphoma. 2024 Mar;65(3):399-402. doi: 10.1080/10428194.2023.2288804. Epub 2023 Dec 9.
No abstract available

MeSH terms

  • Antigens, CD19
  • Feasibility Studies
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Lymphoma* / diagnosis
  • Lymphoma* / therapy
  • Lymphoma, B-Cell* / therapy
  • Receptors, Antigen, T-Cell / genetics

Substances

  • Antigens, CD19
  • Receptors, Antigen, T-Cell